| VAXCYTE INC. DL -,001 |
| USA |
| Gesundheit |
| US92243G1085 / A2P6R6 |
| 5VA (Frankfurt) / PCVX (NASDAQ) |
| FRA:5VA, ETR:5VA, 5VA:GR, NASDAQ:PCVX |
| - |
| https://vaxcyte.com/ |
|
Vaxcyte Inc. is a biotechnology company focused on developing innovative vaccines for preventing infectious diseases. The primary objective of the company is to create safer and more effective vaccines using its proprietary cell-free protein synthesi..
>Volltext.. |
| 7468.91 Mio. EUR |
| 6272.41 Mio. EUR |
| - |
| -984.07 Mio. EUR |
| -919.89 Mio. EUR |
| -6.66 EUR |
| 99.78 Mio. EUR |
| 158.34 Mio. EUR |
| -761.69 Mio. EUR |
| 5.48 |
| - |
| -100.5% |
| - |
| - |
| - |
| 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.253.795 Euro. |
| VAXCYTE |
| 16.08.26 |
|